Compatibility of Cetirizine Hydrochloride, Dutasteride, Hydrocortisone Acetate, Nicotinamide, Progesterone, and Pyridoxine Hydrochloride in TrichoSolTM, A Natural Vehicle for Hair Solutions.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: IJPC Country of Publication: United States NLM ID: 9706294 Publication Model: Print Cited Medium: Print ISSN: 1092-4221 (Print) Linking ISSN: 10924221 NLM ISO Abbreviation: Int J Pharm Compd Subsets: MEDLINE
    • Publication Information:
      Original Publication: Edmond, OK : IJPC, c1997-
    • Subject Terms:
      Niacinamide*/analogs & derivatives ; Niacinamide*/chemistry ; Niacinamide*/administration & dosage ; Hydrocortisone*/analogs & derivatives ; Pyridoxine*/administration & dosage ; Progesterone* ; Cetirizine*/administration & dosage; Humans ; Drug Compounding ; Alopecia/drug therapy ; Drug Stability ; Hair
    • Abstract:
      Compounding pharmacies commonly use ready-to-use vehicles such as TrichoSolTM to produce hair solutions for alopecia. However, chemical and microbiological compatibility are paramount to be determined so those can be safely implemented as the vehicle of choice. This study aimed to assess the physical-chemical and microbiological stabilities of selected active pharmaceutical ingredients in TrichoSolTM. For that, HPLC analyses and Antimicrobial Effectiveness Testing were conducted in bracketed studies. The beyond-use dates (BUDs) found were: 180 days for cetirizine hydrochloride 0.5%-2.0%, dutasteride 0.1%, hydrocortisone acetate 0.5%, nicotinamide 0.25%-0.50%, progesterone 1.0%, and pyridoxine hydrochloride 0.25%-5.0%. BUDs of 150 days were observed for hydrocortisone acetate 1.0%, 120 days for Dutasteride 0.25%, and 90 days for progesterone 2.5%.
      (Copyright© by International Journal of Pharmaceutical Compounding, Inc.)
    • Accession Number:
      25X51I8RD4 (Niacinamide)
      WI4X0X7BPJ (Hydrocortisone)
      KV2JZ1BI6Z (Pyridoxine)
      4G7DS2Q64Y (Progesterone)
      YO7261ME24 (Cetirizine)
      3X7931PO74 (hydrocortisone acetate)
    • Publication Date:
      Date Created: 20241015 Date Completed: 20241015 Latest Revision: 20241015
    • Publication Date:
      20241016
    • Accession Number:
      39405573